Clinical trial
Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to…
NCT00377715 · Medivation, Inc., Industry · Completed
Key facts
| NCT number | NCT00377715 |
|---|---|
| Title | Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease |
| Official title | Phase 2, Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease |
| Lead sponsor | Medivation, Inc., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Dimebon, Placebo |
| Enrollment | 183 |
| Start date | Sep 1, 2005 |
| Primary completion | Aug 1, 2006 |
| First posted | Sep 18, 2006 |
| Last update posted | Nov 11, 2015 |
| Countries | Russia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: